Literature DB >> 6211230

Design of controlled clinical trials: use of historical controls.

E A Gehan.   

Abstract

Mesh:

Substances:

Year:  1982        PMID: 6211230

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


× No keyword cloud information.
  4 in total

1.  Treatment of oxaliplatin-induced peripheral neuropathy by intravenous mangafodipir.

Authors:  Romain Coriat; Jérôme Alexandre; Carole Nicco; Laurent Quinquis; Evelyne Benoit; Christiane Chéreau; Hervé Lemaréchal; Olivier Mir; Didier Borderie; Jean-Marc Tréluyer; Bernard Weill; Joel Coste; François Goldwasser; Frédéric Batteux
Journal:  J Clin Invest       Date:  2013-12-20       Impact factor: 14.808

2.  Frontline treatment of localized osteosarcoma without methotrexate: results of the St. Jude Children's Research Hospital OS99 trial.

Authors:  Najat C Daw; Michael D Neel; Bhaskar N Rao; Catherine A Billups; Jianrong Wu; Jesse J Jenkins; Juan Quintana; Lori Luchtman-Jones; Milena Villarroel; Victor M Santana
Journal:  Cancer       Date:  2011-01-10       Impact factor: 6.860

3.  Survival trial design and monitoring using historical controls.

Authors:  Jianrong Wu; Xiaoping Xiong
Journal:  Pharm Stat       Date:  2016-06-15       Impact factor: 1.894

Review 4.  Trial Design Challenges and Approaches for Precision Oncology in Rare Tumors: Experiences of the Children's Oncology Group.

Authors:  Lindsay A Renfro; Lingyun Ji; Jin Piao; Arzu Onar-Thomas; John A Kairalla; Todd A Alonzo
Journal:  JCO Precis Oncol       Date:  2019-10-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.